2.A study on fetal growth for gestational age.
Ho sung KIM ; Jong Hyang PARK ; Yong Kyoon CHO ; Yong Bong KIM ; Sung Kwan PARK
Korean Journal of Obstetrics and Gynecology 1991;34(2):192-197
No abstract available.
Fetal Development*
;
Gestational Age*
3.A study on fetal growth for gestational age.
Ho sung KIM ; Jong Hyang PARK ; Yong Kyoon CHO ; Yong Bong KIM ; Sung Kwan PARK
Korean Journal of Obstetrics and Gynecology 1991;34(2):192-197
No abstract available.
Fetal Development*
;
Gestational Age*
4.Three cases of potter syndrome.
Kyung Won JUNG ; Hye Sung PARK ; Chang Suh PARK ; Chan Yong PARK ; Sung Jin CHO ; In Suh PARK
Korean Journal of Perinatology 1993;4(2):247-255
No abstract available.
5.A Hospital-based Case-control Study on the Risk Factors of Cerebrovascular Disease.
Jang Rak KIM ; Dae Yong HONG ; Sung Hak PARK
Korean Journal of Preventive Medicine 1995;28(2):473-486
A hospital-based, matched case-control study was carried out to evaluate the relation ship of various suspected risk factors including snoring and serum level of cholesterol to cerebrovascular disease in Korea. A total of 127 incident cases of cerebrovascular disease(74 cases of cerebral infarction and 53 cases of intracerebral hemorrhage) admitted to the department of neurology in a university hospital from December, 1993 to March, 1995 were compared with 127 matched controls admitted to same hospital in same period. A multivariate analysis suggested that ECG abnormality(left ventricular hypertophy and atrial fibrillation), family history of cerebrovascular disease, fundoscopic abnormality, previous history of transient ischemic attack and hypercholesterolemia were risk factors of cerebrovascular disease. ECG abnormality, fundoscopic abnormality, smoking and hypercholesterolemia were also suggested as risk factors of cerebral infarction.
Case-Control Studies*
;
Cerebral Infarction
;
Cholesterol
;
Electrocardiography
;
Humans
;
Hypercholesterolemia
;
Ischemic Attack, Transient
;
Korea
;
Multivariate Analysis
;
Neurology
;
Risk Factors*
;
Ships
;
Smoke
;
Smoking
;
Snoring
6.The Evaluation of SCC (squamous cell carcinoma antigen) Level as a Tumor Marker in Patient with Squamous Cell Carcinoma of the Cervix.
Sung Yong PARK ; Sang Jin KIM ; Hyun Ho KIM
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(4):324-330
This study was performed to evaluate the clinical significance of SCC as a tumor marker in patient with squamous cell carcinoma of the cervix. We measured the serum levels of SCC by radioimmunoassay in patient with invasive squamous cell carcinoma of cervix to determine the prognostic value, correlation with the presence of lymph node metastasis, response to treatment, and those value in the early detection of recurrence after treatment. The result was: 1) In 117 of 174 patients with cervical cancer, the pretreatment positive rate of SCC was 47.0%(57/117). In each stage, the stage Ia was 25.0%, Ib 26.3%, IIa 56.0%, 62.6%, III 57.1%, IV 100%, and the recurrent case was 37.5%. 2) In 79 of 174 patients with cervical cancer, the pretreatment positive rate of SCC was 44,0%(30/69) in no evidence of malignancy patients, but 60.0%(6/10) in recurrent or permanent patients(p>0.05), 3) In 133 of 174 patients with cervical cancer, the posttreatment positive rate of SCC was 2.6%(3/117) in no evidence of malignancy patients, but 50.0%(8/16) in recurrent or permanent patients(p<0.05). 4) In 48 patients of 174 with cervical cancer who underwent radical hystrectomy, the positive rate of SCC was 71.4%(5/7) in pelvic lymph node positive patients but 19,5%(8/41) in pelvic lymph node negative patients(p<0.05). We concluded that the pretreatment SCC level was not effective as a prognostic value, but well correlated with pelvic lymph node metastasis, and serial measurements of serum levels of SCC provided a reliable clue for early detection of recurrence or progression of disease, so it may be useful for monitoring cervical carcinoma patient.
Carcinoma, Squamous Cell*
;
Cervix Uteri*
;
Female
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Radioimmunoassay
;
Recurrence
;
Uterine Cervical Neoplasms
7.33 Cases of Anal Cancer.
Byung Kwon AHN ; Yong Rae PARK ; Sung Uhn BAEK
Journal of the Korean Society of Coloproctology 1998;14(4):743-750
PURPOSE: Malignant disease of the anus is rare. Abdominoperineal resection was formerly considered to be the treatment of choice. But, in recent, less ablative and more effective combined therapeutic modalities have been developed. METHODS: we analyzed 33 patients who were diagnosed and treated as anal cancers at the Department of Surgery, Gospel Hospital, Kosin Medical Collage, from July 1, 1988 to Nov. 30, 1997. RESULTS: The ratio of male to female was 1.4:1 and mean age was 56.7 years old. Twenty-two (84.8%) of these cancers were located in the anal canal and 5 (15.2%) in the anal margin. Three main histologic types of the anal cancers were identified: squamous cell carcinoma was the most common lesion, accounted for 17 cases (51.1%), adenocarcinoma accounted for 8 cases (24.2%), malignant melanoma accounted for 8 cases (24.2%). The overall 3-year survival rate and 5-year survival rate of anal cancer were 54.1%, 41.7%. Eleven patients with squamous cell carcinoma were treated curatively: 6 patients were treated with chemoradiotherapy, 3 patients with abdominoperineal resection, one patient with chemoradiotherapy and abdominoperineal resection, one patient with local excision. CONCLUSION: In survival rate, there were no significant differences between chemoradiotherapy group and surgical treatment group. In squamous cell carcinomas, chemoradiotherapy had anal sparing benefit without loss of survival. On univariate analysis, T, N, type of treatment, histologic type had no statistical significances on survival. On multivariate analysis, location of lesion and distant metastasis had statistical significances.
Adenocarcinoma
;
Anal Canal
;
Anus Neoplasms*
;
Carcinoma, Squamous Cell
;
Chemoradiotherapy
;
Female
;
Humans
;
Male
;
Melanoma
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Survival Rate
8.Changes of Bone Mineral Density and IL-6 Levels after Bilateral Ovariectomies in Rats.
Seung Yeup HAN ; Sung Han KIM ; Keun Yong PARK
Korean Journal of Medicine 1997;53(3):346-351
OBJECTIVE: Estrogen is a major regulator/modulator of bone metabolism, and bone loss in estrogen deficiency is associated with increased bone turnover, But the mechanism for estrogen action on bone metabolism is still unknown. Recent studies have suggested that the increase in bone loss induced by estrogen deficiency is mediated by increased paracrine production of bone resorbing cytokines. Among cytokines, 1nterleukin-6(IL-6) is released from osteoblasts in estrogen deficiency and increases bone resorption by stimulation of osteoclastic activities and recruitment. Thus we performed this study to evaluate the effect of ovariectomies on bone mineral density and IL-6 in cultured monocytes of peripheral blood and bone marrow. METHODS: The experimental animals were 13 female Sprague-Dawley rats that were 8 weeks of age and weighed an average of 188.5 gram at the beginning of the study. Bilateral ovariectomies were performed in all rats from a ventral approach. Bone mineral density(BMD) of the total body, spine and level of IL-6 of cultured monocytes of peripheral blood and bone marrow were measured before and 8 weeks after ovariectomy. RESULTS: 1) BMD of total body and spine were lower after ovariectomy(0.257+/-0.069g/cm2, 0,208+/-0.005g/cm2) than before ovariectomy (0.276+/-0.005g/cm2, 0.229+/-0.011g/cm2), respectively (P<0.01). 2) Although IL-6 level of cultured monocytes in peripheral blood tended to be higher after ovariectomy than before ovariectomy, this difference was not statistically significant (P>0.05). 3) IL-6 level of cultured monocytes in bone marrow was higher after ovariectomy(82.78+/-4.99pg/ml) than before ovariectomy(48.85+/-2.42pg/ml)(P<0.05). CONCLUSION: It is possible that increased production of IL-6 in estrogen deficiency induced by ovariectomy occurs in the local environment of bone or bone marrow rather than in the pheripheral blood and stimulates bone resorption.
Animals
;
Bone Density*
;
Bone Marrow
;
Bone Resorption
;
Cytokines
;
Estrogens
;
Female
;
Humans
;
Interleukin-6*
;
Metabolism
;
Monocytes
;
Osteoblasts
;
Osteoclasts
;
Ovariectomy*
;
Rats*
;
Rats, Sprague-Dawley
;
Spine
9.Reappraisal of Delorme's procedure for rectal prolapse.
Sung Yong YOON ; Joong Kil CHANG ; Seong Dai PARK
Journal of the Korean Surgical Society 1993;44(6):875-880
No abstract available.
Rectal Prolapse*
10.A Case of Tansient Hyperphosphatasemia.
Sung Kee KIM ; Yong Won PARK ; Chong Guk LEE
Journal of the Korean Pediatric Society 2000;43(6):856-860
We examined a male infant with transient increase in alkaline phosphatase(ALP) activity. The 25-month-old infant was admitted to a local hospital because of pneumonia of unknown etiology. Initial laboratory investigation revealed a serum ALP of 11,260U/L, which was comparable to that of bone isoenzyme on the electrophoresis pattern, There was no evidence of hepatitis, skeletal or intestinal diseases. The hyperphosphatasemia disappeared 3 months later. We report a case of transient hyperphosphatasemia diagnosed inci- dentally in the course of management of pneumonia. (J Korean Pediatr Soc 2000;43:856-860)
Alkaline Phosphatase
;
Child, Preschool
;
Electrophoresis
;
Hepatitis
;
Humans
;
Infant
;
Intestinal Diseases
;
Male
;
Pneumonia